Abstract 14745: The Histone Reader PHF7 Cooperates With the SWI/SNF Complex at Cardiac Super Enhancers to Promote Direct Cardiac Reprogramming
In: Circulation ; volume 142, issue Suppl_3 ; ISSN 0009-7322 1524-4539, 2020
academicJournal
Zugriff:
Direct cardiac reprogramming of fibroblasts to cardiomyocytes presents an attractive therapeutic strategy to restore cardiac function following injury. Cardiac reprogramming was initially achieved through the overexpression of the transcription factors Gata4, Mef2c, and Tbx5 (GMT), and later, Hand2 (GHMT) and Akt1 (AGHMT) were found to further enhance this process. Yet, staunch epigenetic barriers severely limit the ability of these cocktails to reprogram adult fibroblasts. We undertook a screen of mammalian gene regulatory factors to discover novel regulators of cardiac reprogramming in adult fibroblasts and identified the histone reader PHF7 as the most potent activating factor. Mechanistically, PHF7 localizes to cardiac super enhancers in fibroblasts, and through cooperation with the SWI/SNF complex, increases chromatin accessibility and transcription factor binding at these sites. Further, PHF7 recruits cardiac transcription factors to activate a core regulatory circuit in reprogramming. Importantly, PHF7 is the first epigenetic factor shown to achieve efficient reprogramming in the absence of Gata4. Here, we highlight the underexplored necessity of cardiac epigenetic modifiers, such as PHF7, in harnessing chromatin remodeling and transcriptional complexes to overcome critical barriers to direct cardiac reprogramming.
Titel: |
Abstract 14745: The Histone Reader PHF7 Cooperates With the SWI/SNF Complex at Cardiac Super Enhancers to Promote Direct Cardiac Reprogramming
|
---|---|
Autor/in / Beteiligte Person: | Garry, Glynnis A ; Bezprozvannaya, Svetlana ; Chen, Kenian ; Zhou, Huanyu ; Hashimoto, Hisayuki ; Morales, Maria G ; Liu, Ning ; Bassel-Duby, Rhonda S ; Olson, Eric N |
Link: | |
Zeitschrift: | Circulation ; volume 142, issue Suppl_3 ; ISSN 0009-7322 1524-4539, 2020 |
Veröffentlichung: | Ovid Technologies (Wolters Kluwer Health), 2020 |
Medientyp: | academicJournal |
DOI: | 10.1161/circ.142.suppl_3.14745 |
Sonstiges: |
|